Año: 2022
Journal Impact Factor (JIF): 4,2
Categoría | Edición | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|---|
MICROBIOLOGY | SCIE | 53/135 | Q2 | T2 | D4 |
INFECTIOUS DISEASES | SCIE | 43/96 | Q2 | T2 | D5 |
IMMUNOLOGY | SCIE | 87/161 | Q3 | T2 | D6 |
Año: 2022
Journal Citation Indicator (JCI): 0,690
Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
---|---|---|---|---|---|
IMMUNOLOGY | 84/177 | Q2 | T2 | D5 | 52,83 |
INFECTIOUS DISEASES | 57/129 | Q2 | T2 | D5 | 56,20 |
MICROBIOLOGY | 68/156 | Q2 | T2 | D5 | 56,73 |
Año:
2022
CiteScore:
6,400
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Infectious Diseases | 85/304 | Q2 | T1 | D3 |
Oncology | 116/366 | Q2 | T1 | D4 |
SJR año:
2022
Factor de Impacto:
1,498
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Infectious Diseases | 38/324 | Q1 | T1 | D2 |
Oncology | 67/375 | Q1 | T1 | D2 |
# | Autor | Afiliación |
---|---|---|
1 | Robinson, Philip | Hoag Memorial Hospital (United States) |
2 | Toussi, Sima S. | Pfizer Inc. (United States) |
3 | Aggarwal, Sudeepta | Pfizer Inc. (United States) |
4 | Bergman, Arthur | Pfizer Inc. (United States) |
5 | Zhu, Tong | Pfizer Inc. (United States) |
6 | Hackman, Frances | Pfizer Limited, UK (United Kingdom) |
7 | Sathish, Jean G. | Pfizer Inc. (United States) |
8 | Updyke, Lawrence | Pfizer Inc. (United States) |
9 | Loudon, Peter | Tenpoint Therapeutics (United Kingdom) |
10 | Krishna, Ganesh | El Camino Health (United States) |
11 | Clevenbergh, Philippe | Centre Hospitalier Universitaire Brugmann, Brussels (Belgium) |
12 | Hernandez-Mora, Miguel Gorgolas | Hospital Universitario Fundación Jiménez Díaz (Spain) |
13 | Cisneros Herreros, Jose Miguel | Hospital Universitario Virgen del Rocío (Spain) |
14 | Albertson, Timothy E. | UC Davis Medical Center (United States) |
15 | Dougan, Michael | Massachusetts General Hospital (United States) |
16 | Thacker, Amber | Regional One Health (United States) |
17 | Baniecki, Mary Lynn | Pfizer Inc. (United States) |
18 | Soares, Holly | Pfizer Inc. (United States) |
19 | Whitlock, Mark | Pfizer Limited, UK (United Kingdom) |
20 | Nucci, Gianluca | Pfizer Limited, UK (United Kingdom) |
21 | Menon, Sandeep | Pfizer Limited, UK (United Kingdom) |
22 | Anderson, Annaliesa S. | Pfizer Limited, UK (United Kingdom) |
23 | Binks, Michael | Pfizer Limited, UK (United Kingdom) |